WASHINGTON, D.C.: The United States has proposed analyzing the genetic information of more than 1 million American volunteers as part of a new initiative to understand human disease and develop medicines targeted to an individual’s genetic make-up.

At the heart of the initiative is the Read More »

BALTIMORE: Over the past several decades there have been a number of well-financed campaigns, promoted by everyday individuals of the public, to raise awareness to the plight of patients with dementia. Suspiciously, most of these campaigns come from “patient support” groups that have been leading  Read More »

BALTIMORE: Consuming multiple cups of coffee a day may reduce an individual’s risk of developing multiple sclerosis (MS), found researchers at Johns Hopkins University School of Medicine.

“Coffee/caffeine intake seems to be protective against Parkinson’s disease and Alzheimer’s disease, leading to a question of whether Read More »

NEW YORK: Zambon S.p.A., an international pharmaceutical company committed to the Central Nervous System (CNS) therapeutic area, and its partner Newron Pharmaceuticals S.p.A., a research and development company focused on novel CNS and pain therapies, has announced that the European Commission has approved the use Read More »